The contractor, through online data subscription and specialized analytic services.
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40121C00070
- Awardee
-
Brightfield Group LLC UEI WJ3QJYH68CR9
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $166,300
Award facts
- Opportunity
-
- FDA21RFQ1243256 Solicitation number
- Contract value 25% obligated
- $669,890.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339999 All Other Miscellaneous Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Funding Only Action | $98,125 | |
| Exercise an Option | $174,378 | |
| Exercise an Option | $231,087 | |
| Other Administrative Action | $0 | |
| Original award | $166,300 |
About this award
The U.S. Food and Drug Administration (FDA) awarded a $669,890 definitive contract to Brightfield Group LLC on July 30, 2021, for online data subscription and specialized analytic services. The contract, which extends through February 4, 2025, supports the FDA's efforts to address knowledge gaps and establish an evidence foundation regarding cannabidiol (CBD), a compound of increasing regulatory interest. No set-aside designation was used for this award, which will be performed in Silver Spring, Maryland.
Brightfield Group LLC, a limited liability partnership specializing in data, research, and analytics services, was selected as the prime contractor with no identified subcontractors. The firm's engagement with federal health agencies is well-established, with prior work for both the FDA and the Centers for Disease Control and Prevention (CDC) on data subscriptions, analytic services, and exploratory research initiatives. Under this firm fixed-price contract, Brightfield Group will provide the data insights and analytical capabilities necessary to inform FDA regulatory and public health decision-making regarding CBD products and their safety and efficacy characteristics.
Quick answers
Who was awarded contract 75F40121C00070?
75F40121C00070 was awarded to Brightfield Group LLC by Food and Drug Administration (Department of Health and Human Services) on July 30, 2021.
How much is contract 75F40121C00070 worth?
The government has obligated $166,300 on 75F40121C00070. Its current value, with exercised options, is $669,890.
Was contract 75F40121C00070 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award